Apellis Pharmaceuticals, Inc.
APLS
$22.01
$0.763.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.96% | 1.83% | 8.63% | 17.04% | -13.28% |
| Total Receivables | 24.89% | -25.78% | -10.27% | 21.04% | 51.86% |
| Inventory | -4.27% | -25.25% | -46.42% | -49.29% | 12.18% |
| Prepaid Expenses | 16.24% | 14.41% | -3.44% | 10.65% | -29.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 171.35% | 85.13% | -19.58% | -39.50% | -51.29% |
| Total Current Assets | 18.80% | -12.14% | -10.32% | 2.95% | 4.66% |
|
|
|||||
| Total Current Assets | 18.80% | -12.14% | -10.32% | 2.95% | 4.66% |
| Net Property, Plant & Equipment | 5.91% | -16.88% | -7.42% | -9.74% | 0.81% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.38% | 101.33% | 4,606.93% | 5,787.09% | 3,945.11% |
| Total Assets | 17.39% | -9.19% | -2.96% | 12.21% | 10.22% |
|
|
|||||
| Total Accounts Payable | -9.66% | 41.73% | 106.39% | 2.81% | 134.88% |
| Total Accrued Expenses | 0.35% | 13.21% | 14.54% | 9.68% | 19.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,381.20% | 19.39% | 10.98% | 4.84% | 18.35% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -95.73% |
| Total Other Current Liabilities | -- | -- | -- | -- | -95.73% |
| Total Current Liabilities | 46.15% | 18.62% | -17.15% | -25.08% | 3.03% |
|
|
|||||
| Total Current Liabilities | 46.15% | 18.62% | -17.15% | -25.08% | 3.03% |
| Long-Term Debt | -20.16% | -0.69% | 386.98% | 386.74% | 386.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.88% | -25.01% | -5.98% | -10.94% | 4.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -66.86% | -22.78% | -99.16% | -96.71% | -96.68% |
| Total Liabilities | -1.08% | 3.89% | 13.77% | 10.49% | 13.45% |
|
|
|||||
| Common Stock & APIC | 3.65% | 3.72% | 3.80% | 7.63% | 8.62% |
| Retained Earnings | 1.50% | -7.76% | -7.70% | -6.97% | -9.10% |
| Treasury Stock & Other | 23.57% | 23.59% | 13.36% | 6.61% | -194.84% |
| Total Common Equity | 69.18% | -40.87% | -38.42% | 17.49% | 2.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 69.18% | -40.87% | -38.42% | 17.49% | 2.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 69.18% | -40.87% | -38.42% | 17.49% | 2.09% |
|
|
|||||